PFE - Pfizer Inc

PFE - Pfizer Inc

https://www.pfizer.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Pfizer Inc. ( PFE ) is Attracting Investor Attention: Here is What You Should Know

Zacks Commentary • 2 hours, 43 minutes ago • score: 0.17

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths

Zacks Commentary • 2 hours, 47 minutes ago • score: -0.03

MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.

Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap? - Altria Group ( NYSE:MO ) , LyondellBasell Industries ( NYSE:LYB )

Benzinga • 20 hours, 11 minutes ago • score: -0.10

LyondellBasell's 10% yield comes amid earnings miss and negative free cash flow. Pfizer and Altria face pressure from patent cliffs and declining volumes. Up Next: Wall Street trader's 34-0 strategy goes public this week. See it first →

1 Reason Every Investor Should Know About Pfizer ( PFE ) Stock

Motley Fool • 2 days, 7 hours ago • score: 0.41

How does $700 in annual income sound for every $10,000 in shares owned?

Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths - Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE ) , BioNTech ( NASDAQ:BNTX )

Benzinga • 2 days, 20 hours ago • score: 0.04

Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump administration officials plan to link the shots to 25 child deaths. Want to trade this news? Get access to the 34-0 income strategy that loves volatility →

OLMA Stock Soars 47% in September So Far on Second PFE Deal

Zacks Commentary • 3 days, 1 hour ago • score: 0.25

Olema Pharmaceuticals surges 47% in September after striking a second collaboration with Pfizer for its lead breast cancer product candidate, palazestrant.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.

52W High

$28.43

52W Low

$20.18

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.46

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

13.16

Forward P/E (<15 better)

7.97

EV/EBITDA (<8 favorable)

9.38

EV/Revenue (<3 favorable)

2.96

P/S (TTM) (<3 favorable)

2.22

P/B (<3 favorable)

1.60

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

0.07%

Institutions (25–75% balanced)

67.12%

Shares Outstanding

5,685,550,000

Float

5,675,885,000

Dividend Yield (2–6% sweet spot)

0.07%

Ex‑Dividend Date

2025-07-25

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

63,833,002,000

Gross Profit (TTM)

47,120,998,000

EPS (TTM)

1.89

Profit Margin (>10% good)

0.17%

Operating Margin (TTM) (higher better)

0.29%

ROE (TTM) (>15% strong)

0.12%

EPS YoY (Quarterly) (>10% good)

69.74

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Bearish momentum

Value

-0.0949

Previous

0.0031

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025